SX-517

• CAT Number: I008853
• CAS Number: 1240494-13-6
• Molecular Formula: C19H16BFN2O3S
• Molecular Weight: 382.22
• Purity: ≥95%
• Synonyms: [2-[[5-[(4-fluorophenyl)carbamoyl]pyridin-2-yl]sulfanylmethyl]phenyl]boronic acid
• InChI: InChI=1S/C19H16BFN2O3S/c21-15-6-8-16(9-7-15)23-19(24)13-5-10-18(22-11-13)27-12-14-3-1-2-4-17(14)20(25)26/h1-11,25-26H,12H2,(H,23,24)
• InChIKey: VZRIHFZJVIOJBE-UHFFFAOYSA-N
• SMILES: B(C1=CC=CC=C1CSC2=NC=C(C=C2)C(=O)NC3=CC=C(C=C3)F)(O)O

SX-517（Cat No.:I008853）is a small molecule compound being studied for its potential therapeutic applications, particularly in oncology. It is designed to target specific enzymes, receptors, or signaling pathways that contribute to cancer cell proliferation, survival, and resistance to treatment. SX-517 has shown promise in preclinical studies for inhibiting tumor growth and overcoming resistance mechanisms, especially in cancers that are difficult to treat with conventional therapies. Researchers are exploring its role in combination therapies to enhance efficacy. Ongoing clinical trials are necessary to assess its safety, pharmacokinetics, and overall therapeutic potential in cancer treatment.